Debu Tripathy, MD, discusses the evolving treatment landscape of HER2-positive breast cancer.
Debu Tripathy, MD, The University of Texas MD Anderson Cancer Center
Advertisement
Articles by Debu Tripathy, MD, The University of Texas MD Anderson Cancer Center
Advertisement
Latest Updated Articles
Dr. Tripathy on the Evolving Treatment Landscape of HER2+ Breast CancerSeptember 2nd 2020
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026
3
FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer
4
The OncFive: Top Oncology Articles for the Week of 5/31
5